Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Filled!!!
Next Wednesday will be like Christmas morning for the folks here, IMHO.
Yes, both Surgibot and ALF-X have been displayed publicly.
I think they froze the design when they decided to build seven copies of SPORT...
Also interesting is watching these buy orders go unfilled for long periods of time. The 57k on the bid is just sitting .008 below the 10k order on the ask, but both refuse to budge. IMHO, the buyers are behaving like they have something to gain from an impending pop by getting onboard as low as possible...
Compared to the abysmal performance we've had recently, seeing a few 100k orders in one day is really intriguing. Especially on no real news...
I can't believe how much buying is going on today. These new IR guys must be going through their Rolodex. There was another 93k buy a few minutes ago that is slowly getting chipped away.
What are your reasons?
Spiffy!
JMAC - I am skeptical about the picture you're trying to paint of Lavin/BTIGs decision not to cover Titan. I followed up with him last year after the 2nd annual Snowbird conference, and he told me at that time that they simply do not discuss why they are or are not covering a company they've met with, nor the timing of when they'll pick up coverage of any given company. Your post sounded way to definitive to have Lavin as the source.
I also followed up with mgmt this week on the SPORT being at AORN, and they said that's absolutely still happening.
Are you just trying to spread FUD to drive the price down for your own gain? Level with us here....
The reason I'm putting my chips on SAGES is that I believe that real world demonstration of the robot in front of surgeons who would actually use it will finally get some buzz going in the medical community. Titan has a great location next to the entrance and the food in the exhibit hall, so even a surgeon who has never heard of SPORT will see it and may then seek more details.
I also tend to think that surgeons have more disposable income than your average retail investor. I'm betting at least a few of them will see the robot and consider Titan as an investment.
Surgeons aside, you also have a hall of about 1000 device reps who (as we've seen from LinkedIn) may immediately recognize the surgical value of the device in the marketplace. They, too, tend to be avid investors in this stuff.
I've noticed that volume bump, too. It's certainly worth watching..,
But that is exactly what I did...I contacted mgmt and they confirmed the presence of the unit at AORN. What further DD would you recommend so that I can read between the tea leaves here?
JMAC, I'm not sure what you're getting at. I asked if the system will be at AORN and they said:
"We will be exhibit this year and have reserved booth 2600. We will be showcasing the full system patient cart and workstation."
Bloom Burton to host 60 Canadian medtech companies (including Titan) for two day conference in May:
http://m.bloomburton.com/conference-2015/
Nothing in life is ever promised, but it sure would be nice if BTIG saw the potential in SPORT and gave the stock a "Buy" rating. They've done so for other sub-$1 stocks before.
Adrock, keep in mind that the BTIG conference is not a "get on stage and present" affair. It's more like a one-on-one event.
I emailed Dr. Sean Lavin at BTIG after last year's conference, and he indicated that they get all of the companies together so that they can hear what they have in the pipeline to determine who to cover and how to cover them in their research notes for the year. My feeling is that Titan was too pre-product last year to get mentioned, but that we might see something come out of this year's meeting since they now have a finished unit.
The FDA allows devices without 510(k) to be shown at conferences like SAGES, as long as the conference is targeted at medical professionals and the device is clearly labeled as not being for sale in the US.
Also, you can simply pick up the phone or fire an email off to Titan to confirm that they'll be showing the robot in person at both conferences...
LTG, I agree that ALF-X is a completely different technology from SPORT. But if it wants to compete with daVinci Xi, they need to re-brand it so docs won't think of this:
http://images6.fanpop.com/image/photos/36900000/Alf-salon-fauteuil-alf-36950357-1600-1200.jpg
Looks like 495k shares sold at 10:03am for 0.60. If you use the iHub app, you can see these trades on the "Trades" tab
I stand corrected. If you look here, they have up to 90 days from year-end to post their audited financials:
http://www.canaglobecompliance.com/faq-1a.html
Periscope or Meerkat streaming from SAGES would be ideal BelizeMe.
We already know the costs changed a bit HC...just read the prospectus supplement.
I would not be surprised if they wait for SAGES and AORN to release any new video. For me, the first day of SAGES will officially mark the transition from development to commercialization for this company.
They are right next to the sim center at AORN, which is a great, high traffic spot IMHO...
Roll call...who is going to SAGES?
28 days until SAGES
TSX is closed today for Family Day.
Same story picked up on InsideBayStreet:
http://www.insidebaystreet.com/two-weeks-in-the-life-of-a-titan-medical-shareholder-its-been-quite-the-ride/
With 29 patents and 5 robots, one could probably get a title loan from Gary Coleman to cover commercialization
Product page on Titan's website got a update last night:
http://www.titanmedicalinc.com/product/
There is an interesting explanation of the cost increase in the prospectus. It's on SEDAR and worth a read (sorry, don't have time to paste the text here right now).
Noticed in the new prospectus that the cost of the first five in human SPORT units crept up by $4.4M. On the flip side, the expected cost of the human trials dropped by about $4M.
As of the end of 2015, Titan had $11M in the bank, and had already paid for $4.7M toward the in-human robots. The new funding should get them to the end of this milestone.
Clever.
So if you bought the offering at .90 with the 1.00 warrant, you're probably upset because the PPS is now .76. The underwriter created the over allotment to smooth this out. If you buy a unit of the over allotment on top of the earlier unit, you have two shares at .90, a third share for .25, and a potential fourth share for 1.00. The average price of these four shares is (you guessed it) .76
Planning to call them post MD&A. The deadline for that is 2/15...
Someone selling 148,900...that has to be the mother of all shorts...
Big blocks on the bid/ask....nice action despite the share price
Agree.
When did we add an "-ic" to the company name?